EKTERLY
NDC 82928-300, sebetralstat, tablet, from KalVista Pharmaceuticals Ltd.
- Product NDC
- 82928-300
- Status
- Listed
- Labeler
- KalVista Pharmaceuticals Ltd
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219301
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82928-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SEBETRALSTAT300 mg/1
Pharmacologic classes
Kallikrein Inhibitors [MoA]; Plasma Kallikrein Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82928-300-04 | 82928030004 | 4 BLISTER PACK in 1 CARTON (82928-300-04) / 1 TABLET in 1 BLISTER PACK (82928-300-01) |
| 82928-300-05 | 82928030005 | 2 BLISTER PACK in 1 CARTON (82928-300-05) / 2 TABLET in 1 BLISTER PACK (82928-300-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1d145e2f-8e7e-2e90-e063-6294a90a4449
Use it
Look up 82928-300 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82928-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82928-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.